Fallowfield's Sexual Activity Questionnaire in women with without and at risk of cancer

Menopause International

Volumn 13, Issue 3, 2007, Pages 103-109

  Atkins, Louise ^a   Fallowfield, Lesley j ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

AGE; CANCER; FALLOWFIELD'S SEXUAL ACTIVITY QUESTIONNAIRE (FSAQ); MENOPAUSE; SEXUAL ACTIVITY

Indexed keywords

ANASTROZOLE; EXEMESTANE; RALOXIFENE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CHEMOPROPHYLAXIS; CONTROL GROUP; CONTROLLED STUDY; FALLOWFIELD SEXUAL ACTIVITY QUESTIONNAIRE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONAL THERAPY; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MASTECTOMY; MENTAL STRESS; MORBIDITY; OVARY CANCER; PAIN; POSTMENOPAUSE; PREMENOPAUSE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; UTERINE CERVIX CANCER; VAGINA DISCHARGE; VAGINAL DRYNESS; AGE DISTRIBUTION; BREAST TUMOR; HEALTH STATUS; LIBIDO; MIDDLE AGED; OVARY TUMOR; PRECANCER; PSYCHOMETRY; PSYCHOSEXUAL DISORDER; UNITED KINGDOM; WOMEN'S HEALTH;

ADULT; AGE DISTRIBUTION; BREAST NEOPLASMS; FEMALE; GREAT BRITAIN; HEALTH STATUS; HUMANS; LIBIDO; MIDDLE AGED; OVARIAN NEOPLASMS; PRECANCEROUS CONDITIONS; PSYCHOMETRICS; QUESTIONNAIRES; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; STRESS, PSYCHOLOGICAL; WOMEN'S HEALTH;

EID: 38449096877     PISSN: 17540453     EISSN: None     Source Type: Journal    
DOI: 10.1258/175404507781605578     Document Type: Article

References (33)

1. Addis IB, Van Den Eeden SK, Wassel-Fyr CL, Vittinghoff E, Brown JS, Thom DH. Sexual activity and function in middleaged and older women. Obstet Gynecol 2006;107:755–64.
2. Blumel J, Castelo-Branco C, Cancelo M, Romero H, Aprikian D, Sarra S. Impairment of sexual activity in middle-aged women in Chile. Menopause 2004;11:78–81.
3. Conde D, Pinto-Neto A, Cabello C, Sa D, Costa-Paiva L, Martinez E. Menopause symptoms and quality of life in women aged 45 to 65 years with and without breast cancer. Menopause 2005;12:436–43.
4. Elit L, Esplen M, Butler K, Narod S. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Fam Cancer 2001;1:149–56.
5. Madalinska JB, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 2005;23:6890–8.
6. Malinovszky K, Gould A, Foster E, et al. Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. Br J Cancer 2006;95:1626–31.
7. Ganz P, Rowland J, Desmond K, Meyerowitz B, Wyatt G. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501–14.
8. Avis N, Crawford S, Manuel J. Psychosocial problems among younger women with breast cancer. Psychooncology 2004;13:295–308.
9. Broeckel J, Thors C, Jacobsen P, Small M, Cox C. Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 2002;75:241–8.
10. Fallowfield LJ, Baum M, Maguire GP. Effects of breast conservation on the psychological morbidity associated with the diagnosis and treatment of early breast cancer. BMJ 1986;293:1331–4.
11. Hatcher MB, Fallowfield L, A'Hern R. The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ 2001;322:76–9.
12. Bruner D, Lanciano R, Keegan M, Corn B, Martin E, Hanks G. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys 1993;27:825–30.
13. Jensen P, Groenvold M, Klee M, Thranov I, Petersen M, Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2003;56:937–49.
14. Frumovitz M, Sun CC, Schover LR, et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 2005;23:7428–36.
15. Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A. Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 2004;22:4261–71.
16. Fallowfield LJ, Bliss JM, Porter LS, et al. Quality of life in the Intergroup Exemestane Study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 2006;24:910–17.
17. Land SR, Wickerham DL, Costantino JP, et al. Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295: 2742–51.
18. Stead ML, Brown JM, Fallowfield L, Selby P. Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer 2003;88:666–71.
19. Mishra GKuh D. Sexual functioning throughout menopause: the perceptions of women in a British cohort. Menopause 2006;13:880–90.
20. Derogatis L, Rust J, Golombok S, et al. Validation of the Profile of Female Sexual Function (PFSF) in surgically and naturally menopausal women. J Sex Marital Ther 2004;30:25–36.
21. McHorney CA, Rust J, Golombok S, et al. Profile of Female Sexual Function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women. Menopause 2004;11:474–83.
22. Thirlaway K, Fallowfield L, Cuzick J. The Sexual Activity Questionnaire: a measure of women's sexual functioning. Qual Life Res 1996;5:81–90.
23. Stead ML, Crocombe WD, Fallowfield LJ, et al. Sexual activity questionnaires in clinical trials: acceptability to patients with gynaecological disorders. Br J Obstet Gynaecol 1999;106:50–4.
24. Fallowfield L, Fleissig A, Edwards R, et al. Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. J Clin Oncol 2001;19:1885–92.
25. Fobair P, O'Hanlan K, Koopman C, et al. Comparison of lesbian and heterosexual women's response to newly diagnosed breast cancer. Psychooncology 2001;10:40–51.
26. Fry A, Busby-Earle C, Rush R, Cull A. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer. Psychooncology 2001;10:231–41.
27. Stead M. Identification and Assessment of Quality of Life Issues in Patients with Cancer. Unpublished PhD thesis, University of Leeds, 2001.
28. Kessel B, Nachtigall L, Plouffe L, Siddhanti S, Rosen A, Parsons A. Effect of raloxifene on sexual function in postmenopausal women. Climacteric 2003;6:248–56.
29. Carmack Taylor CL, Basen-Engquist K, Shinn EH, Bodurka DC. Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol 2004;22:881–9.
30. Fallowfield LJ, Jacobs I. Psychosocial Implications of the UK Collaborative Trial of Screening for Ovarian Cancer (UKCTOCS) (Protocol), 2000.
31. Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G. Manual for the State–Trait Anxiety Inventory (Form Y1–Y2). Palo Alto, CA: Consulting Psychology Press, 1983.
32. Goldberg D. Manual of the General Health Questionnaire. Windsor: NFER-Nelson, 1978.
33. Dennerstein L, Lehert P, Burger H, Dudley E. Factors affecting sexual functioning of women in the mid-life years. Climacteric 1999;2:254–62.